Cannabis Cultivation Market Scope
Cannabis cultivation refers to growing cannabis, either in a commercial facility or in a home garden. There are various states where medical cannabis is legalized and they provide cannabis cards which allowed to grow a certain number of plants at home for personal use and also the same for commercial. Increasing demand for cannabis in the medical industry and legalization of cannabis boosting the cannabis cultivation market in the forecasted period.
The market study is being classified by Type (Indoor Cannabis Cultivation and Outdoor Cannabis Cultivation), by Application (Pharmaceutical, Food & Beverages, Personal Care & Cosmetics and Other) and major geographies with country level break-up.
Research Analyst at AMA predicts that Canada Vendors will contribute to the maximum growth of Global Cannabis Cultivation market throughout the predicted period.
Canopy Growth Corporation (Canada), Aphria Inc. (Canada), Aurora Cannabis Inc (Canada), Tilray (Canada), GW Pharmaceuticals (United Kingdom), CAB International (United Kingdom), Organigram Holdings Inc (Canada), Applied DNA Sciences Inc (United States), The Cronos Group (Canada) and Wayland Group Corp.(Canada) are some of the key players profiled in the study.
AdvanceMarketAnalytics has segmented the market of Global Cannabis Cultivation market by Type, Application and Region.
On the basis of geography, the market of Cannabis Cultivation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In June 2019 , Applied DNA Sciences Inc. announced that its strategic partner to the global cannabis industry, TheraCann International Benchmark Corporation (“TheraCann”), has secured a collaboration agreement with House of Hemp (HoH). The collaboration includes the implementation of TheraCann’s molecular-tagging ETCH biotrace technology that uses a physical molecular tag exclusively supplied by Applied DNA. TheraCann was selected by HoH to be their technical expert and project management team to achieve the medical GMP standard for international cannabis export and to provide the necessary technologies to track every gram, every penny, and to ensure crop quality and reliability.
Canada had recently passed a nationwide legalization of recreational cannabis use, following Uruguay to become the second country to do so. According to CBC, Canada is one of only two countries, besides the Netherlands, that exports cannabis products, which allows companies in Canada to gain instant revenue from recent medical cannabis.
- Use of Advanced Techniques in Cannabis Cultivation
- Increasing Demand for Cannabis Globally
- Growing Legalization of Medical Cannabis in Various Countries
- Rising Number of Countries Legalizing Cannabis Cultivation such as Canada, the United States, Australia, Belgium, Mexico, etc.
- The High Demand for Cannabis in Medical Industry
- Stringent Government Regulations for Cannabis Cultivation in Some Countries
Key Target Audience
Cannabis Manufacturers, Cannabis Suppliers/ Distributors, Healthcare Industry, Research Organization, Governmental Bodies and Potential Investors
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase